Dopeksamin

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
Dopeksamin
(IUPAC) ime
4-[2-({6-[(2-feniletil)amino]heksil}amino)etil]benzen-1,2-diol
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 86197-47-9
ATC kod C01CA14
PubChem[1][2] 55483
ChemSpider[3] 50102
UNII 398E7Z7JB5 DaY
KEGG[4] D03891 DaY
ChEMBL[5] CHEMBL77622 DaY
Hemijski podaci
Formula C22H32N2O2 
Mol. masa 429,43 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Dopeksamin je β1 i β2 adrenergički agonist[6]. On takođe deluje na dopaminskim receptorima.[7]

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  6. Perrin G, Papazian L, Martin C. (1993). „Dopexamine: a new dopaminergic agonist”. Ann Fr Anesth Reanim. 12 (3): 308–320. PMID 7902685. 
  7. Brown RA, Dixon J, Farmer JB, et al. (July 1985). „Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors”. Br. J. Pharmacol. 85 (3): 599–608. PMC 1916510. PMID 2862944. 

Spoljašnje veze

[uredi | uredi kod]